Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 33, 2009 - Issue 5
863
Views
120
CrossRef citations to date
0
Altmetric
PROCEEDINGS 17TH ICOC Shenzhen, PR China, November 2007

Oxidative Stress, Diabetes, and Diabetic Complications

, , , , &
Pages 370-377 | Published online: 12 Oct 2009

REFERENCES

  • Cai L, Kang YJ. Oxidative stress and diabetic cardiomyopathy: a brief review. Cardiovasc Toxicol. 2001; 1(3):181–193.
  • Wang YH. Diabetes/obesity-related inflammation,cardiac cell death and cardiomyopathy. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2006; 31(6):814–818.
  • Zheng Y, Li XK, Wang G, Lin X, Cai L. The role of zinc, copper and iron in the pathogenesis of diabetes and diabetic complications: therapeutic effects by chelators. Hemoglobin. 2008; 32(1–2):135–145.
  • Liu Q, Sun L, Tan Y, Role of iron deficiency and overload in the pathogenesis of diabetes and diabetic complications. Curr Med Chem. 2009; 16(1):113–129.
  • Kang YJ, Cai L. Metallothionein supperssion of diabetic cardiomyopathy by inhibition of hyperglycemia-induced oxidative stress. Free Radic Biol Med. 2001; 31(1):33.
  • Liang Q, Carlson EC, Donthi RV, Overexpression of metallothionein reduces diabetic cardiomyopathy. Diabetes. 2002; 51(1):174–181.
  • Cai L, Wang J, Li Y, Inhibition of superoxide generation and associated nitrosative damage is involved in metallothionein prevention of diabetic cardiomyopathy. Diabetes. 2005; 54(6):1829–1837.
  • Song Y, Wang J, Li Y, Cardiac metallothionein synthesis in streptozotocin-induced diabetic mice, and its protection against diabetes-induced cardiac injury. Am J Pathol. 2005; 167(1):17–26.
  • Cai L, Wang Y, Zhou G, Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy. J Am Coll Cardiol. 2006; 48(8):1688–1697.
  • Cai L. Suppression of nitrative damage by metallothionein in diabetic heart contributes to the prevention of cardiomyopathy. Free Radic Biol Med. 2006; 41(6):851–861.
  • Zheng S, Carlson EC, Yang L, Podocyte-specific overexpression of the antioxidant metallothionein reduces diabetic nephropathy. J Am Soc Nephrol. 2008; 19(11):2077–2085.
  • Li X, Cai L, Feng W. Diabetes and metallothionein. Mini Rev Med Chem. 2007;7; (7):761–768.
  • Beltramini M, Zambenedetti P, Raso M, IbnlKayat MI, Zatta P. The effect of Zn(II) and streptozotocin administration in the mouse brain. Brain Res. 2006; 1109(1):207–218.
  • Gupta R, Garg VK, Mathur DK, Goyal RK. Oral zinc therapy in diabetic neuropathy. J Assoc Physicians India. 1998; 46(11):939–942.
  • Hayee MA, Mohammad QD, Haque A. Diabetic neuropathy and zinc therapy. Bangladesh Med Res Council Bull. 2005; 31(2):62–67.
  • Hussain SA, Khadim HM, Khalaf BH, Effects of melatonin and zinc on glycemic control in type 2 diabetic patients poorly controlled with metformin. Saudi Med J. 2006; 27(10):1483–1488.
  • Facchiano F, D'Arcangelo D, Russo K, Glycated fibroblast growth factor-2 is quickly produced in vitro upon low-millimolar glucose treatment and detected in vivo in diabetic mice. Mol Endocrinol. 2006; 20(11):2806–2818.
  • Beenken A, Mohammadi M. The FGF family: biology, pathophysiology and therapy. Nat Rev Drug Discov. 2009; 8(3):235–253.
  • Lin ZF, Li XK, Lin Y, Protective effects of non-mitogenic human acidic fibroblast growth factor on hydrogen peroxide-induced damage to cardiomyocytes in vitro. World J Gastroenterol. 2005; 11(35):5492–5497.
  • Li XK, Lin ZF, Li Y, Cardiovascular protection of nonmitogenic human acidic fibroblast growth factor from oxidative damage in vitro and in vivo. Cardiovasc Pathol. 2007; 16(2):85–91.
  • Song Y, Song Z, Zhang L, Diabetes enhances lipopolysaccharide-induced cardiac toxicity in the mouse model. Cardiovasc Toxicol. 2003; 3(4):363–372.
  • Yeboah J, Sane DC, Crouse JR, Low plasma levels of FGF-2 and PDGF-BB are associated with cardiovascular events in type II diabetes mellitus (diabetes heart study). Dis Markers. 2007; 23(3):173–178.
  • Wang W, Lin S, Xiao Y, Acceleration of diabetic wound healing with chitosan-crosslinked collagen sponge containing recombinant human acidic fibroblast growth factor in healing-impaired STZ diabetic rats. Life Sci. 2008; 82(3–4):190–204.
  • Tan Y, Xiao J, Huang Z, Comparison of the therapeutic effects between recombinant human acidic and basic fibroblast growth factors in wound healing in diabetic patients. J Health Sci. 2008; 54(4):423–440.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.